Central endothelin ETB receptors mediate IL-1-dependent fever induced by preformed pyrogenic factor and corticotropin-releasing factor in the rat

1 Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; 2 Department of Pharmacology, Biological Sciences Center, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil; 3 Department of Pharmacology, Biolo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2006-01, Vol.290 (1), p.R164
Hauptverfasser: Fabricio, Aline S. C, Rae, Giles A, Zampronio, Aleksander R, D'Orleans-Juste, Pedro, Souza, Gloria E. P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; 2 Department of Pharmacology, Biological Sciences Center, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil; 3 Department of Pharmacology, Biological Sciences Section, Universidade Federal do Paraná, Curitiba, Paraná, Brazil; 4 Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Canada Submitted 11 May 2005 ; accepted in final form 19 August 2005 Blockade of central endothelin ET B receptors inhibits fever induced by LPS in conscious rats. The contribution of ET B receptor-mediated mechanisms to fever triggered by intracerebroventricular IL-6, PGE 2 , PGF 2 , corticotropin-releasing factor (CRF), and preformed pyrogenic factor derived from LPS-stimulated macrophages (PFPF) was examined. The influence of natural IL-1 receptor antagonist or soluble TNF receptor I on endothelin (ET)-1-induced fever was also assessed. The selective ET B receptor antagonist BQ-788 (3 pmol icv) abolished fever induced by intracerebroventricular ET-1 (1 pmol) or PFPF (200 ng) and reduced that caused by ICV CRF (1 nmol) but not by IL-6 (14.6 pmol), PGE 2 (1.4 nmol), or PGF 2 (2 nmol). CRF-induced fever was also attenuated by bosentan (dual ET A /ET B receptor antagonist; 10 mg/kg iv) but unaffected by BQ-123 (selective ET A receptor antagonist; 3 pmol icv). -Helical CRF 9–41 (dual CRF 1 /CRF 2 receptor antagonist; 6.5 nmol icv) attenuated fever induced by CRF but not by ET-1. Human IL-1 receptor antagonist (9.1 pmol) markedly reduced fever to IL-1 (180 fmol) or ET-1 and attenuated that caused by PFPF or CRF. Murine soluble TNF receptor I (23.8 pmol) reduced fever to TNF- (14.7 pmol) but not to ET-1. The results of the present study suggest that PFPF and CRF recruit the brain ET system to cause ET B receptor-mediated IL-1-dependent fever. prostaglandins; cytokines; interleukin-1 receptor antagonist Address for reprint requests and other correspondence: G. E. P. Souza, Laboratório de Farmacologia, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av. do Café, s/n-Campus USP 14040-903 Ribeirão Preto, SP, Brazil (E-mail: gepsouza{at}usp.br )
ISSN:0363-6119
1522-1490
DOI:10.1152/ajpregu.00337.2005